Duragesic and Cefazolin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Duragesic (fentanyl) and Cefazolin (cefazolin sodium). Common drug interactions include intervertebral disc protrusion among females and drug toxicity among males.

The phase IV clinical study analyzes what interactions people have when they take Duragesic and Cefazolin. It is created by eHealthMe based on reports of 75 people who take the same drugs from the FDA, and is updated regularly.

What is Duragesic?

Duragesic has active ingredients of fentanyl. eHealthMe is studying from 66,597 Duragesic users. Check the latest studies of Duragesic.

What is Cefazolin?

Cefazolin has active ingredients of cefazolin sodium. It is often used in infection. eHealthMe is studying from 15,157 Cefazolin users. Check the latest studies of Cefazolin.



On Jul, 12, 2026

75 people who take Duragesic and Cefazolin together, and have interactions are studied.

Duragesic and Cefazolin drug interactions.

What are the common drug interactions of Duragesic and Cefazolin, by gender? *:

female:

  1. Intervertebral disc protrusion (spinal disc protrusion)
  2. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  3. Osteonecrosis of jaw (death of bone of jaw)
  4. Spinal osteoarthritis (joint cartilage loss in spine)
  5. Urinary tract infection
  6. Asthma
  7. Osteomyelitis (infection of bone)
  8. Arthropathy
  9. Diarrhoea
  10. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)

male:

  1. Drug toxicity
  2. Hypertensive heart disease
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Deafness
  5. Death
  6. Foot fracture
  7. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  8. Osteomyelitis (infection of bone)
  9. Osteonecrosis of jaw (death of bone of jaw)
  10. Pain in extremity

What are the common drug interactions of Duragesic and Cefazolin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  2. Drug toxicity
  3. Back pain
  4. Pain in extremity
  5. Abdominal distension
  6. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  7. Overdose
  8. Unresponsive to stimuli
  9. Accidental death
  10. Application site pain

20-29:

n/a

30-39:

  1. Abdominal pain
  2. Anaemia (lack of blood)
  3. Anxiety
  4. Appendicitis (inflammation of the appendix)
  5. Arthropathy
  6. Bipolar i disorder (mood disorder that is characterized by at least one manic or mixed episode)
  7. Bone pain
  8. Breast cancer recurrent
  9. Confusional state
  10. Constipation

40-49:

  1. Abnormal behaviour
  2. Aggression
  3. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  4. Anxiety disorder
  5. Device occlusion
  6. Drug dependence
  7. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  8. Dyspnoea (difficult or laboured respiration)
  9. Eating disorder
  10. Hospitalisation

50-59:

  1. Osteonecrosis of jaw (death of bone of jaw)
  2. Pain in extremity
  3. Sinusitis (inflammation of sinus)
  4. Swelling
  5. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  6. Mastication disorder (disease of chewing food)
  7. Mouth ulceration (mouth ulcers)
  8. Oral candidiasis (fungal infection of mouth)
  9. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  10. Abscess oral (abscess in the mouth)

60+:

  1. Renal failure (kidney dysfunction)
  2. Anxiety
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Diarrhoea
  5. Emotional distress
  6. Fear
  7. Multi-organ failure (multisystem organ failure)
  8. Pain
  9. Stress
  10. Back pain

What are the existing conditions these people have? *

  1. Pain: 23 people, 30.67%
  2. Multiple Myeloma (cancer of the plasma cells): 16 people, 21.33%
  3. High Blood Pressure: 15 people, 20.00%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 14 people, 18.67%
  5. Metastases To Bone (cancer spreads to bone): 13 people, 17.33%
  6. Breakthrough Pain: 13 people, 17.33%
  7. Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 13 people, 17.33%
  8. Bacterial Infection: 13 people, 17.33%
  9. Acid Fast Bacilli Infection (mycobacterium tuberculosis infection-hiv patient): 13 people, 17.33%
  10. Procedural Pain: 12 people, 16.00%

* Approximation only. Some reports may have incomplete information.

Do you take Duragesic and Cefazolin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Duragesic and Cefazolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Duragesic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cefazolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Duragesic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefazolin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fentanyl and cefazolin sodium (the active ingredients of Duragesic and Cefazolin, respectively), and Duragesic and Cefazolin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: